New York, NY, United States of America

Lin-Chi Chen

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Hoffmann-La Roche Inc.. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lin-Chi Chen. Retrieved from https://idiyas.com/inventor/lin-chi-chen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Lin-Chi Chen: Innovator in Anti-Tumor Therapy

Introduction

Lin-Chi Chen is a notable inventor based in New York, NY (US). He has made significant contributions to the field of medicine, particularly in the development of new treatment methodologies for cancer.

Latest Patents

Lin-Chi Chen holds a patent for a method of administration that introduces a new dosage regimen for Compound A. This innovative approach maximizes anti-tumor activity while maintaining acceptable toxicity levels. His work in this area is crucial for improving patient outcomes in cancer treatment.

Career Highlights

Chen is currently employed at Hoffmann-La Roche Inc., a leading pharmaceutical company known for its commitment to advancing healthcare. His role at the company allows him to work on groundbreaking research and development projects that aim to enhance therapeutic options for patients.

Collaborations

Throughout his career, Lin-Chi Chen has collaborated with esteemed colleagues, including Brian Higgins and Gwen Nichols. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Lin-Chi Chen's contributions to anti-tumor therapy exemplify the impact of innovative thinking in medicine. His patent and work at Hoffmann-La Roche Inc. highlight his dedication to improving cancer treatment methodologies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…